
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Human Gut Microbiota in Coronary Artery Disease: A Systematic Review and Meta-Analysis
Marcin Choroszy, Kamil Litwinowicz, Robert Bednarz, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1165-1165
Open Access | Times Cited: 34
Marcin Choroszy, Kamil Litwinowicz, Robert Bednarz, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1165-1165
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Gut microbiota and derived metabolites mediate obstructive sleep apnea induced atherosclerosis
Jin Xue, Celeste Allaband, Simone Zuffa, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Jin Xue, Celeste Allaband, Simone Zuffa, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease
Curtis L. Gabriel, Jane F. Ferguson
Circulation Research (2023) Vol. 132, Iss. 12, pp. 1674-1691
Open Access | Times Cited: 21
Curtis L. Gabriel, Jane F. Ferguson
Circulation Research (2023) Vol. 132, Iss. 12, pp. 1674-1691
Open Access | Times Cited: 21
Banxia Xiexin decoction alleviates AS co-depression disease by regulating the gut microbiome-lipid metabolic axis
Xing-Xing Liao, Ke Hu, Xie Xinhua, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116468-116468
Open Access | Times Cited: 17
Xing-Xing Liao, Ke Hu, Xie Xinhua, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116468-116468
Open Access | Times Cited: 17
Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?
Giovanni Cimmino, Francesco Natale, Roberta Alfieri, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2353-2353
Open Access | Times Cited: 13
Giovanni Cimmino, Francesco Natale, Roberta Alfieri, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2353-2353
Open Access | Times Cited: 13
Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis
Meiling Cai, Lingyu Lin, Fei Jiang, et al.
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 12, pp. 1053-1068
Open Access | Times Cited: 13
Meiling Cai, Lingyu Lin, Fei Jiang, et al.
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 12, pp. 1053-1068
Open Access | Times Cited: 13
The gut microbiome across the cardiovascular risk spectrum
Femke M. Prins, Valerie Collij, Hilde E. Groot, et al.
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 8, pp. 935-944
Open Access | Times Cited: 11
Femke M. Prins, Valerie Collij, Hilde E. Groot, et al.
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 8, pp. 935-944
Open Access | Times Cited: 11
The Beneficial Effects of Dietary Astragali Radix Are Related to the Regulation of Gut Microbiota and Its Metabolites
Ling Wang, Lan Yang, Xiao-Ling Cheng, et al.
Journal of Medicinal Food (2024) Vol. 27, Iss. 1, pp. 22-34
Closed Access | Times Cited: 4
Ling Wang, Lan Yang, Xiao-Ling Cheng, et al.
Journal of Medicinal Food (2024) Vol. 27, Iss. 1, pp. 22-34
Closed Access | Times Cited: 4
Poly(D,l-lactide-co-glycolide) particles are metabolised by the gut microbiome and elevate short chain fatty acids
Laura E. McCoubrey, Fabiana Ferraro, Nidhi Seegobin, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 163-178
Open Access | Times Cited: 4
Laura E. McCoubrey, Fabiana Ferraro, Nidhi Seegobin, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 163-178
Open Access | Times Cited: 4
Gut Microbiota and Their Metabolites as Modulators of Vascular Complications in Diabetes
Meng Yun Duan, Jielu Wen, Anning Chen, et al.
(2025), pp. 2-2
Open Access
Meng Yun Duan, Jielu Wen, Anning Chen, et al.
(2025), pp. 2-2
Open Access
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
Jinpeng Jing, Jing Guo, Rui Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Jinpeng Jing, Jing Guo, Rui Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Gut Microbiota and Vascular Diseases: An Update
Jiaqi Wu, Yuxuan Li, Peipei Yang, et al.
Cardiovascular Innovations and Applications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Jiaqi Wu, Yuxuan Li, Peipei Yang, et al.
Cardiovascular Innovations and Applications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Gut Microbiota and Its Metabolites: The Emerging Bridge Between Coronary Artery Disease and Anxiety and Depression?
Haiyang Chen, Lijun Zhang, Yanwei Li, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Haiyang Chen, Lijun Zhang, Yanwei Li, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
New Modifiable Risk Factors Influencing Coronary Artery Disease Severity
Kamila Florek, M.-Dominique Kubler, Magdalena Górka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7766-7766
Open Access | Times Cited: 3
Kamila Florek, M.-Dominique Kubler, Magdalena Górka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7766-7766
Open Access | Times Cited: 3
Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology
Boyao Zhang, Thierry Schmidlin
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Boyao Zhang, Thierry Schmidlin
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease
A. A. Yafarova, Elena V. Dementeva, Olga A. Zlobovskaya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11295-11295
Open Access | Times Cited: 3
A. A. Yafarova, Elena V. Dementeva, Olga A. Zlobovskaya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11295-11295
Open Access | Times Cited: 3
Genetic support of the causal association between gut microbiota and peripheral artery disease: a bidirectional Mendelian randomization study
Hongshuo Shi, Xin Yuan, Fangfang Wu, et al.
Aging (2024)
Open Access | Times Cited: 2
Hongshuo Shi, Xin Yuan, Fangfang Wu, et al.
Aging (2024)
Open Access | Times Cited: 2
The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology
Hao-Ming Zhou, Xinyu Yang, Shi‐Jun Yue, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 145-155
Open Access | Times Cited: 2
Hao-Ming Zhou, Xinyu Yang, Shi‐Jun Yue, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 145-155
Open Access | Times Cited: 2
Intestinal fatty acid binding protein is associated with coronary artery disease in long-term type 1 diabetes—the Dialong study
Marte Narum, Ingebjørg Seljeflot, Vibeke Bratseth, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Marte Narum, Ingebjørg Seljeflot, Vibeke Bratseth, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches
Nitesh Gautam, Joshua Mueller, Omar Alqaisi, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 12, pp. 1069-1081
Closed Access | Times Cited: 6
Nitesh Gautam, Joshua Mueller, Omar Alqaisi, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 12, pp. 1069-1081
Closed Access | Times Cited: 6
Association between Intestinal Microecological Changes and Atherothrombosis
Xinyu Zhuo, Hui Luo, Rumei Lei, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1223-1223
Open Access | Times Cited: 5
Xinyu Zhuo, Hui Luo, Rumei Lei, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1223-1223
Open Access | Times Cited: 5
Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Yusheng Wang, Yandan Xie, Gehendra Mahara, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Yusheng Wang, Yandan Xie, Gehendra Mahara, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Gut microbiota at different stages of cardiovascular disease continuum
A. A. Yafarova, E. D. Dementyeva, Olga A. Zlobovskaya, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 22, Iss. 12, pp. 3751-3751
Open Access | Times Cited: 1
A. A. Yafarova, E. D. Dementyeva, Olga A. Zlobovskaya, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 22, Iss. 12, pp. 3751-3751
Open Access | Times Cited: 1
Two cosmoses, one universe: a narrative review exploring the gut microbiome's role in the effect of urban risk factors on vascular ageing
Lara Anne Bridge, Juliana Alexandra Hernández Vargas, Silvia Juliana Trujillo-Cáceres, et al.
Maturitas (2024) Vol. 184, pp. 107951-107951
Open Access | Times Cited: 1
Lara Anne Bridge, Juliana Alexandra Hernández Vargas, Silvia Juliana Trujillo-Cáceres, et al.
Maturitas (2024) Vol. 184, pp. 107951-107951
Open Access | Times Cited: 1
Addressing the Missing Links in Cardiovascular Aging
Elliot Dinetz, Claudia Zeballos‐Palacios, Claudia Martinez
Clinical Interventions in Aging (2024) Vol. Volume 19, pp. 873-882
Open Access | Times Cited: 1
Elliot Dinetz, Claudia Zeballos‐Palacios, Claudia Martinez
Clinical Interventions in Aging (2024) Vol. Volume 19, pp. 873-882
Open Access | Times Cited: 1
Leaky gut in systemic inflammation: exploring the link between gastrointestinal disorders and age-related diseases
Jonathan Escalante, Olivia Artaiz, Shanti Diwakarla, et al.
GeroScience (2024)
Open Access | Times Cited: 1
Jonathan Escalante, Olivia Artaiz, Shanti Diwakarla, et al.
GeroScience (2024)
Open Access | Times Cited: 1